We are live on ! Find out more
BCB

Brian C. Broderick Portfolio holdings

AUM $542M
1-Year Est. Return 20.28%
This Fund
S&P 500
This Quarter Est. Return
-3.24%
1 Year Est. Return
+20.28%
3 Year Est. Return
+64.8%
5 Year Est. Return
+86.99%
10 Year Est. Return
+301.53%
AUM
$320M
AUM Growth
-$9.77M
Cap. Flow
+$7.08M
Cap. Flow %
2.21%
Top 10 Hldgs %
39.2%
Holding
79
New
8
Increased
24
Reduced
29
Closed

Top Buys

Rank Stock Value
1
MDT icon
Medtronic
MDT
+$604K
2
NVDA icon
NVIDIA
NVDA
+$547K
3
UNH icon
UnitedHealth
UNH
+$450K
4
MRNA icon
Moderna
MRNA
+$379K
5
ADBE icon
Adobe
ADBE
+$378K

Top Sells

Rank Stock Value
1
MMM icon
3M
MMM
+$642K
2
CNI icon
Canadian National Railway
CNI
+$305K
3
HON icon
Honeywell
HON
+$279K
4
UNP icon
Union Pacific
UNP
+$222K
5
NVS icon
Novartis
NVS
+$164K

Sector Composition

Rank Sector Weight
1 Technology 23.7%
2 Healthcare 23.3%
3 Industrials 13.02%
4 Consumer Discretionary 8.56%
5 Consumer Staples 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NVDA icon
26
NVIDIA
NVDA
$4.92T
$4.61M 1.44%
379,530
+34,590
+10% +$547K
PEP icon
27
PepsiCo
PEP
$185B
$3.8M 1.19%
23,265
-610
-3% -$105K
EW icon
28
Edwards Lifesciences
EW
$48.9B
$3.77M 1.18%
45,653
+3,650
+9% +$351K
CVX icon
29
Chevron
CVX
$378B
$3.73M 1.17%
25,954
-284
-1% -$43.3K
NKE icon
30
Nike
NKE
$64.5B
$3.37M 1.05%
40,576
+1,416
+4% +$152K
XOM icon
31
ExxonMobil
XOM
$615B
$3.12M 0.97%
35,725
-164
-0.5% -$15K
ILMN icon
32
Illumina
ILMN
$27.9B
$2.86M 0.9%
15,432
-257
-2% -$50.8K
MDT icon
33
Medtronic
MDT
$107B
$2.8M 0.88%
34,727
+6,722
+24% +$604K
NVS icon
34
Novartis
NVS
$285B
$2.31M 0.72%
30,405
-1,980
-6% -$164K
CHD icon
35
Church & Dwight Co
CHD
$23.2B
$2.22M 0.69%
31,128
+3,235
+12% +$279K
APTV icon
36
Aptiv
APTV
$12.1B
$1.83M 0.57%
23,347
+2,720
+13% +$261K
ABBV icon
37
AbbVie
ABBV
$448B
$1.75M 0.55%
13,012
-225
-2% -$32.3K
SPTM icon
38
State Street SPDR Portfolio S&P 1500 Composite Stock Market ETF
SPTM
$13.5B
$1.32M 0.41%
30,000
WELL icon
39
Welltower
WELL
$173B
$1.19M 0.37%
18,500
+3,500
+23% +$274K
BMY icon
40
Bristol-Myers Squibb
BMY
$123B
$832K 0.26%
11,700
IRWD icon
41
Ironwood Pharmaceuticals
IRWD
$634M
$818K 0.26%
79,000
-4,500
-5% -$51K
PBA icon
42
Pembina Pipeline
PBA
$29.5B
$665K 0.21%
21,901
-399
-2% -$14.2K
BDX icon
43
Becton Dickinson
BDX
$42.6B
$663K 0.21%
2,976
-290
-9% -$72.2K
TT icon
44
Trane Technologies
TT
$103B
$575K 0.18%
3,970
TMO icon
45
Thermo Fisher Scientific
TMO
$196B
$545K 0.17%
1,075
INTC icon
46
Intel
INTC
$488B
$534K 0.17%
20,740
-1,250
-6% -$42.6K
MRK icon
47
Merck
MRK
$307B
$487K 0.15%
5,650
NVO
48
Novo Nordisk
NVO
$219B
$452K 0.14%
9,070
-330
-4% -$17.7K
KO icon
49
Coca-Cola
KO
$353B
$407K 0.13%
7,280
COP icon
50
ConocoPhillips
COP
$141B
$401K 0.13%
3,919

Similar funds

Brian C. Broderick's Q3 2022 Portfolio in Review

As of Q3 2022, Brian C. Broderick held 79 positions worth $320M, down 3% from $330M the previous quarter. Its ten largest holdings account for 39% of the portfolio.

Brian C. Broderick's Q3 2022 filing shows 8 new, 24 increased and 29 reduced positions. Its largest new stake was Moderna: 2,500 shares worth $296K. The largest sale was 3M, an estimated $642K.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Healthcare and Industrials.

  • Brian C. Broderick's largest Q3 2022 buy was Moderna: 2,500 shares worth $296K.
  • Brian C. Broderick added most to Medtronic in Q3 2022, an estimated $604K increase.
  • Brian C. Broderick's biggest Q3 2022 reduction was 3M, cutting an estimated $642K.
  • Brian C. Broderick's ten largest holdings make up 39% of its $320M portfolio in Q3 2022.
  • Brian C. Broderick opened 8 new positions and closed 0 in Q3 2022.
  • Brian C. Broderick's portfolio value fell 3% quarter-over-quarter to $320M.

Based on Brian C. Broderick's 13F filing for Q3 2022, filed 8 Nov 2022.